Mohamed Maher | Material Science | Impactful Research Award
Dr. Mohamed Maher, University of Texas Southwestern Medical Center, United States.
Publication profile
Scopus
Education and Experience
Education 
- Ph.D. in Cancer Biology (Molecular Virology and Immunology) – National Cancer Institute, Cairo University, Egypt (2011–2017)
- M.Sc. in Pharmaceutical Sciences (Microbiology and Immunology) – Assiut University, Egypt (2006–2010)
- B.Sc. in Pharmaceutical Sciences – Assiut University, Egypt (1998–2003)
Experience 
- Senior Research Assistant – MD Anderson Cancer Center, Houston, TX (2022–Present)
- Postdoctoral Fellow – MD Anderson Cancer Center, Houston, TX (2019–2022)
- Lecturer of Cancer Biology, Virology, and Immunology – South Egypt Cancer Institute, Assiut University, Egypt (2017–Present)
- Assistant Lecturer – South Egypt Cancer Institute, Assiut University, Egypt (2015–2017)
Suitability For The Award
Dr. Mohamed Maher stands as a distinguished cancer researcher whose transformative contributions to molecular diagnostics and cancer genomics make him an ideal candidate for the prestigious Impactful Research Award. His innovative work in cancer genotyping, particularly in liquid biopsies, solid tumors, and hematological malignancies, underscores his dedication to advancing diagnostic precision and improving patient outcomes. Dr. Maher’s expertise, blending his background as a Clinical Pharmacist, Cancer Biologist, and Molecular Diagnostic innovator, highlights his remarkable ability to translate cutting-edge research into real-world clinical applications, creating a lasting impact in cancer research and diagnostics.
Professional Development
Publications Top Notes
-
“A rapid turnaround time workflow for a cytological liquid biopsy assay using FNA supernatant specimens” (Maher, M.H., et al., 2025, Cancer Cytopathology) –
2025 |
Open Access |
-
“Dinutuximab synergistically enhances the cytotoxicity of natural killer cells to retinoblastoma through the perforin-granzyme B pathway” (Wang, H., et al., 2020, OncoTargets and Therapy) –
2020 |
8 Citations